Abstract Accepted by the European Congress of Immunology (ECI 2024)

We are excited to announce that our abstract titled “Performance characteristics of a novel, fully automated immunoassay microarray for the qualitative serological detection of specific IgE directed against Bet v 1” has been accepted by the European Congress of Immunology (ECI 2024), a major international event on immunology, to be held in Dublin, Ireland, from 1 to 4 September 2024. Accepted abstracts will be published in the European Journal of Immunology.

The abstract, which is AliveDx’s first scientific communication in the Allergy segment, showed positive results in analytical comparison and precision evaluations, demonstrating the assay’s robustness.

Trending Topics

Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.

December 10, 2024

AliveDx Announces Multiple Evaluation Sites of its MosaiQ® Solution

AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases. We are
December 5, 2024

Join us at the upcoming International Friday Meeting

We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.
November 11, 2024

AliveDx Suisse S.A. and Medikonia Limited Sign Distribution Agreement in Hong Kong and Macau

AliveDx Suisse S.A. and Medikonia Limited have signed a distribution agreement, which will enable Medikonia to distribute the MosaiQ® solution in Hong Kong and Macau. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence
November 8, 2024

AliveDx Becomes a Member of BIVDA

We are proud to announce that we have become a member of BIVDA, the UK’s leading IVD industry association. BIVDA is the national industry association for manufacturers and distributors of medical diagnostic tests in the UK, representing 97% of the
October 24, 2024

AliveDx Suisse S.A. and Bio-State Inc. Sign Distribution Agreement in India

AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s
October 3, 2024

Join us at AABB 2024!

Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab! Sign up for a booth meeting with your Account Executive today.